Clinical Trial: A Study to Learn About How Loss of Liver Function Affects the Blood Levels of the Study Medicine Called PF-07817883.
Study Status: Completed
Recruit Status: RECRUITING
Condition: COVID-19
Study Type: INTERVENTIONAL
Official Title: A PHASE 1, OPEN-LABEL, SINGLE-DOSE, PARALLEL GROUP STUDY TO ASSESS PHARMACOKINETICS, SAFETY AND TOLERABILITY OF PF-07817883 IN ADULT PARTICIPANTS WITH VARYING DEGREES OF HEPATIC IMPAIRMENT RELATIVE TO
Brief Summary:
The purpose of the study is to learn about the safety of PF-07817883 and how PF-07817883 is processed in the body of adult participants.These participants will have different degrees of loss of liver function.Participants with mild, moderate, severe or no loss of liver function will be enrolled in 4 groups.This study is seeking participants who:are male or female of 18- 75 years of ageeither have different amounts of damage to liver function or for one of the groups, no damagewilling to follow the requirements of…
Read more